Press Research sCD14

New research links IC14 target to dementia

New research published in the world’s leading journal Neurology reports a link between higher levels of an inflammatory marker called sCD14 and a higher risk of developing dementia.  The study looked at blood samples and dementia diagnosis of more than 4,700 people over a decade. Researchers found that people with higher blood levels of sCD14 […]


Australian Immunotherapy Selected for Revolutionary US Clinical Trial Platform Debut

An Australian immunotherapy drug will receive a huge boost when it is tested with four other new concepts across 54 clinical sites across the USA in a search for an effective treatment for ALS (a motor neuron disease). This bold initiative will see Implicit Bioscience’s IC14 entering an elite pivotal clinical study in the first […]